1. Home
  2. CCCC vs PSBD Comparison

CCCC vs PSBD Comparison

Compare CCCC & PSBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

HOLD

Current Price

$4.25

Market Cap

404.7M

Sector

Health Care

ML Signal

HOLD

PSBD

Palmer Square Capital BDC Inc.

HOLD

Current Price

$10.79

Market Cap

333.6M

Sector

N/A

ML Signal

HOLD

Company Overview

Basic Information
Metric
CCCC
PSBD
Founded
2015
2009
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
404.7M
333.6M
IPO Year
2020
2019

Fundamental Metrics

Financial Performance
Metric
CCCC
PSBD
Price
$4.25
$10.79
Analyst Decision
Strong Buy
Hold
Analyst Count
6
9
Target Price
$12.20
$12.33
AVG Volume (30 Days)
2.4M
115.1K
Earning Date
05-06-2026
05-06-2026
Dividend Yield
N/A
15.02%
EPS Growth
16.45
N/A
EPS
N/A
1.66
Revenue
$35,947,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$6.46
Revenue Growth
1.02
N/A
52 Week Low
$1.40
$9.34
52 Week High
$4.60
$14.87

Technical Indicators

Market Signals
Indicator
CCCC
PSBD
Relative Strength Index (RSI) 61.49 51.96
Support Level $2.10 $10.44
Resistance Level $4.60 $11.00
Average True Range (ATR) 0.36 0.17
MACD 0.00 0.00
Stochastic Oscillator 72.60 64.86

Price Performance

Historical Comparison
CCCC
PSBD

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

About PSBD Palmer Square Capital BDC Inc.

Palmer Square Capital BDC Inc is a financial services company that lends to and invests in corporate debt securities of companies, including small to large private U.S. companies. Their investment objective is to maximize total return, comprised of current income and capital appreciation.

Share on Social Networks: